25 results on '"Targowska-Duda, Katarzyna M."'
Search Results
2. Type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransmitter reuptake inhibition. Correlation with mTOR intracellular pathway activation
3. N-(3-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}propyl)-1H-indazole-3-carboxamide (D2AAK3) as a potential antipsychotic: In vitro, in silico and in vivo evaluation of a multi-target ligand
4. NOP receptor agonist attenuates nitroglycerin-induced migraine-like symptoms in mice
5. Corrigendum to “In vitro, molecular modeling and behavioral studies of '3-{[4-(5-methoxy-1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]methyl}-1,2-dihydroquinolin-2-one (D2AAK1) as a potential antipsychotic” [Neurochem. Int. 96 (2016) 84–99]
6. Positive allosteric modulators of α7 nicotinic acetylcholine receptors affect neither the function of other ligand- and voltage-gated ion channels and acetylcholinesterase, nor β-amyloid content
7. In vitro, molecular modeling and behavioral studies of 3-{[4-(5-methoxy-1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]methyl}-1,2-dihydroquinolin-2-one (D2AAK1) as a potential antipsychotic
8. The positive allosteric modulator of α7 nicotinic acetylcholine receptors, 3-furan-2-yl-N-p-tolyl-acrylamide, enhances memory processes and stimulates ERK1/2 phosphorylation in mice
9. The antidepressant-like activity of nicotine, but not of 3-furan-2-yl- N - p -tolyl-acrylamide, is regulated by the nicotinic receptor β4 subunit
10. Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites
11. Synthesis, in vitro and in vivo studies, and molecular modeling of N-alkylated dextromethorphan derivatives as non-competitive inhibitors of α3β4 nicotinic acetylcholine receptor
12. Bupropion-induced inhibition of α7 nicotinic acetylcholine receptors expressed in heterologous cells and neurons from dorsal raphe nucleus and hippocampus
13. Antidepressant activity in mice elicited by 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor
14. Corrigendum to: “Structural and functional interaction of (±)-2-(N-tert-butylamino)-3′-iodo-4′-azidopropiophenone, a photoreactive bupropion derivative, with nicotinic acetylcholine receptors”, [Neurochem Int 2012 61 (8), 1433–1441]
15. Role of the nicotinic receptor β4 subunit in the antidepressant activity of novel N,6-dimethyltricyclo[5.2.1.02,6]decan-2-amine enantiomers
16. Structural and functional interaction of (±)-2-(N-tert-butylamino)-3′-iodo-4′-azidopropiophenone, a photoreactive bupropion derivative, with nicotinic acetylcholine receptors
17. Structure–activity relationship of ibogaine analogs interacting with nicotinic acetylcholine receptors in different conformational states
18. Interaction of Tricyclic Antidepressants with the Hα3β4 Nicotinic Receptor
19. Interaction of 18-Methoxycoronaridine with Nicotinic Acetylcholine Receptors in Different Conformational States
20. Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptors
21. Interaction of ibogaine with human α3β4-nicotinic acetylcholine receptors in different conformational states
22. Interaction of 18-methoxycoronaridine with nicotinic acetylcholine receptors in different conformational states
23. Tricyclic antidepressants and mecamylamine bind to different sites in the human α4β2 nicotinic receptor ion channel
24. Different interaction between tricyclic antidepressants and mecamylamine with the human α3β4 nicotinic acetylcholine receptor ion channel
25. Comparative Interaction of Tricyclic Antidepressants and Mecamlyamine with the Human α4β2 Nicotinic Acetylcholine Receptor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.